• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.79% Nasdaq Up 0.53%

    PDL BioPharma, Inc. (PDLI)

    -NasdaqGS
    6.41 Down 0.02(0.31%) Jul 1, 4:00PM EDT
    Add to Portfolio
    Prev Close:6.43
    Open:6.45
    Bid:6.10 x 1000
    Ask:7.10 x 10000
    1y Target Est:7.00
    Beta:0.9
    Earnings Date:Aug 17 - Aug 21 (Est.)
    Day's Range:6.30 - 6.52
    52wk Range:6.18 - 10.26
    Volume:2,922,308
    Avg Vol (3m):3,011,480
    Market Cap:1.05B
    P/E (ttm):3.34
    EPS (ttm):1.92
    Div & Yield:0.60 (9.20%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PDLI

    Comparison

    Symbol% ChgMkt Cap
    PDLIDown 0.31%1.05B
    AMGNUp 0.96%117.84B
    SGENDown 1.20%5.97B
    XOMADown 3.35%441.81M

    Key Statistics

    Forward P/E (1 yr):9.86
    P/S (ttm):2.11
    Ex-Dividend Date:02-Dec-15

    Analysts

    Annual EPS Est (Dec-15) :2.11
    Quarterly EPS Est (Jun-15) :0.52
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):0.22

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    PDL BioPharma, Inc. manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback